Sfoglia per Autore
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis
2017-01-01 Perrotta, F. M.; Guerra, G.; De Socio, A.; Scriffignano, S.; Lubrano, E.
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study
2018-01-01 Perrotta, Fabio Massimo; de Socio, Antonia; Scriffignano, Silvia; Lubrano, Ennio
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications
2018-01-01 Perrotta, Fabio Massimo; De Socio, Antonia; Scriffignano, Silvia; Lubrano, Ennio
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study
2018-01-01 Perrotta, Fabio Massimo; Ceccarelli, Fulvia; Barbati, Cristiana; Colasanti, Tania; De Socio, A; Scriffignano, S; Alessandri, C; Lubrano, E.
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis
2018-01-01 Scriffignano, S; Perrotta, F; De Socio, A; Altobelli, A; Sessa, P; Scrivo, R; Valesini, G; Lubrano, E.
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study
2019-01-01 Perrotta, Fabio Massimo; Scriffignano, Silvia; Lubrano, Ennio
Role of comorbidities in spondyloarthritis including psoriatic arthritis
2019-01-01 Scriffignano, Silvia; Perrotta, Fabio Massimo; De Socio, Antonia; Lubrano, Ennio
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting
2019-01-01 Lubrano, Ennio; Scriffignano, Silvia; De Socio, Antonia; Perrotta, Fabio Massimo
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings
2019-01-01 Perrotta, Fabio Massimo; Scriffignano, Silvia; De Socio, Antonia; Lubrano, Ennio
Residual disease activity and associated factors in Psoriatic Arthritis
2019-01-01 Lubrano, Ennio; Scriffignano, Silvia; Perrotta, Fabio Massimo
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome?
2019-01-01 Lubrano, E.; Scriffignano, S.; Perrotta, F. M.
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
2019-01-01 Lubrano, Ennio; Perrotta, Fabio Massimo; Scriffignano, Silvia; Coates, Laura C; Helliwell, Philip
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis
2019-01-01 Lubrano, E.; Scriffignano, S.; Perrotta, F. M.
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report
2019-01-01 Perrotta, F M; Scriffignano, S; De Socio, A; Lubrano, E
Dr. Lubrano, et al reply
2020-01-01 Lubrano, E.; Scriffignano, S.; Perrotta, F. M.
Multimorbidity and comorbidity in psoriatic arthritis–a perspective
2020-01-01 Lubrano, E.; Scriffignano, S.; Perrotta, F. M.
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study
2020-01-01 Lubrano, Ennio; Scriffignano, Silvia; Azuaga, Ana Belen; Ramirez, Julio; Cañete, Juan D; Perrotta, Fabio Massimo
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study
2020-01-01 Perrotta, F M; Delle Sedie, A; Scriffignano, S; Volpe, P; Cordisco, E; Milano, N; Gabini, M; Lubrano, E
Rheumatology Care in the Face of COVID-19
2020-01-01 Lubrano, Ennio; Scriffignano, Silvia; Perrotta, Fabio Massimo
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices
2020-01-01 Lubrano, E.; Scriffignano, S.; Azuaga, A. B.; Ramirez, J.; Canete, J.; Perrotta, F. M.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile